| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0009-9236(96)80007-5 |
| P698 | PubMed publication ID | 8653992 |
| P2093 | author name string | Benet LZ | |
| Chang T | |||
| Hebert MF | |||
| P2860 | cites work | Noncompartmental Determination of the Steady‐State Volume of Distribution | Q34218917 |
| Cyclosporins as drug resistance modifiers | Q35250358 | ||
| Clinical pharmacokinetics of cyclosporin | Q39729593 | ||
| On the dose dependency of cyclosporin A absorption and disposition in healthy volunteers | Q42655150 | ||
| The absorption site of cyclosporin in the human gastrointestinal tract | Q43224181 | ||
| Effect of food on the pharmacokinetics of cyclosporine in healthy subjects following oral and intravenous administration | Q44822103 | ||
| Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine* | Q44872539 | ||
| The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine* | Q46085210 | ||
| Transport and metabolism of cyclosporine in isolated rat hepatocytes. The effects of lipids | Q46604852 | ||
| Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction | Q46791680 | ||
| Reduced cyclosporin accumulation in multidrug-resistant cells. | Q54385146 | ||
| Improvement of cyclosporin absorption in children after liver transplantation by means of water-soluble vitamin E | Q68307018 | ||
| Absorption of water-miscible forms of vitamin E in a patient with cholestasis and in thoracic duct-cannulated rats | Q69680803 | ||
| Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation | Q72528001 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pharmacokinetics | Q323936 |
| cyclosporine | Q367700 | ||
| P304 | page(s) | 297-303 | |
| P577 | publication date | 1996-03-01 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | The effect of water-soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers | |
| P478 | volume | 59 |
| Q48685663 | A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model |
| Q34665881 | A mechanistic approach to understanding the factors affecting drug absorption: a review of fundamentals |
| Q36611637 | A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer |
| Q36371996 | Advances in the use of tocols as drug delivery vehicles |
| Q31966507 | Bioadhesive properties of hydroxypropylcellulose topical films produced by hot-melt extrusion |
| Q34451869 | Block copolymeric biotransport carriers as versatile vehicles for drug delivery |
| Q33904220 | Contributions of hepatic and intestinal metabolism and P-glycoprotein to cyclosporine and tacrolimus oral drug delivery |
| Q64079416 | Development and mechanistic study of a microemulsion containing vitamin E TPGS for the enhancement of oral absorption of celecoxib |
| Q39397339 | Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats |
| Q43272019 | Development of microemulsion of mitotane for improvement of oral bioavailability. |
| Q33587865 | Dosage and formulation issues: oral vitamin E therapy in children |
| Q26824259 | Drug Delivery Innovations for Enhancing the Anticancer Potential of Vitamin E Isoforms and Their Derivatives |
| Q44027605 | Drug interaction studies between paclitaxel (Taxol) and OC144-093--a new modulator of MDR in cancer chemotherapy |
| Q34239257 | Drug-nutrient interactions in transplant recipients |
| Q32135883 | Effect of 6 weeks of vitamin E administration on renal haemodynamic alterations following a single dose of neoral in healthy volunteers |
| Q42545396 | Effect of diltiazem on concentration of cyclosporin metabolites in Sandimmune and Neoral treated kidney transplant patients |
| Q44119555 | Effects of formulation and dosing strategy on amprenavir concentrations in the seminal plasma of human immunodeficiency virus type 1-infected men. |
| Q44123431 | Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers |
| Q41889524 | Enhanced Permeability of Etoposide across Everted Sacs of Rat Small Intestine by Vitamin E-TPGS. |
| Q44247758 | Enhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in rats |
| Q52666672 | Evidences for anti-mycobacterium activities of lipids and surfactants. |
| Q40619069 | Excipient effects on in vitro cytotoxicity of a novel paclitaxel self‐emulsifying drug delivery system |
| Q44148712 | Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension |
| Q44367040 | Influence of micelle solubilization by tocopheryl polyethylene glycol succinate (TPGS) on solubility enhancement and percutaneous penetration of estradiol |
| Q74072075 | Influence of vitamin E TPGS on the properties of hydrophilic films produced by hot-melt extrusion |
| Q41701150 | Inhibition of P-glycoprotein by D-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS). |
| Q40923441 | Intestinal MDR transport proteins and P-450 enzymes as barriers to oral drug delivery |
| Q34384325 | Intestinal drug efflux: formulation and food effects |
| Q59485374 | Lipid-based vehicles for the oral delivery of poorly water soluble drugs |
| Q35178040 | Paclitaxel in self-micro emulsifying formulations: oral bioavailability study in mice |
| Q34579721 | Pharmacokinetics of cinacalcet hydrochloride when administered with ketoconazole |
| Q36987997 | Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies |
| Q44277753 | Physicochemical characterization of solid dispersion of furosemide with TPGS. |
| Q41364364 | Physiochemical and physiological mechanisms for the effects of food on drug absorption: the role of lipids and pH. |
| Q37141404 | Polymeric micelles and alternative nanonized delivery vehicles for poorly soluble drugs |
| Q30451024 | Polymeric micelles, a promising drug delivery system to enhance bioavailability of poorly water-soluble drugs. |
| Q35179026 | Preparation and evaluation of quercetin-loaded lecithin-chitosan nanoparticles for topical delivery |
| Q46055776 | Role of P-glycoprotein and cytochrome P450 3A in limiting oral absorption of peptides and peptidomimetics |
| Q37824886 | Selected pharmacokinetic issues of the use of antiepileptic drugs and parenteral nutrition in critically ill patients |
| Q44645197 | Solubilization of cyclosporin A in dextran-g-polyethyleneglycolalkyl ether polymeric micelles |
| Q44532726 | The association between vitamin C and vitamin E supplement use before hematopoietic stem cell transplant and outcomes to two years |
| Q33787485 | The contribution of P-glycoprotein to pharmacokinetic drug-drug interactions |
| Q34384318 | The drug efflux-metabolism alliance: biochemical aspects. |
| Q37485904 | The drug transporter-metabolism alliance: uncovering and defining the interplay |
| Q52920247 | The potential replacement of HPLC by 125I-RIA for the characterization of cyclosporin A: a bioavailability study after oral administration in healthy human subjects. |
| Q30729351 | Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). |
| Q52082695 | Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. |
Search more.